[1,2]diazocane-3,8-dione | 861611-10-1

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: [1,2]diazocane-3,8-dione
• 英文别名: hexahydro-[1,2]diazocine-3,8-dione；Hexahydro-[1,2]diazocin-3,8-dion；1,8-Diaza-2,7-dioxo-cyclooctan；Adipinsaeuredihydrazid；Hexahydro-1,2-diazocine-3,8-dione；diazocane-3,8-dione
• CAS: 861611-10-1
• 化学式: C₆H₁₀N₂O₂
• 分子量: 142.158
• InChiKey: RAPQCYAOUAQSEA-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  -0.6
• 重原子数：
  10
• 可旋转键数：
  0
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.67
• 拓扑面积：
  58.2
• 氢给体数：
  2
• 氢受体数：
  2

反应信息

• 作为产物：
  描述：

  己二酸二乙酯 在 乙醇 、 碘 、 一水合肼 作用下， 生成 [1,2]diazocane-3,8-dione
  参考文献：
  名称：

  Curtius, Journal fur praktische Chemie (Leipzig 1954), 1915, vol. <2> 91, p. 23

  摘要：

  DOI：

文献信息

• Capping Bioprosthetic Tissue to Reduce Calcification
  申请人：Dove Jeffery

  公开号：US20090164005A1

  公开（公告）日：2009-06-25

  A treatment for bioprosthetic tissue used in implants or for assembled bioprosthetic heart valves to reduce in vivo calcification. The method includes applying a calcification mitigant such as a capping agent or an antioxidant to the tissue to specifically inhibit oxidation in tissue. Also, the method can be used to inhibit oxidation in dehydrated tissue. The capping agent suppresses the formation of binding sites in the tissue that are exposed or generated by the oxidation and otherwise would, upon implant, attract calcium, phosphate, immunogenic factors, or other precursors to calcification. In one method, tissue leaflets in assembled bioprosthetic heart valves are pretreated with an aldehyde capping agent prior to dehydration and sterilization.

  一种用于植入物中使用的生物假体组织的处理方法，或者用于组装的生物假体心脏瓣膜以减少体内钙化。该方法包括将钙化减轻剂（如包埋剂或抗氧化剂）应用于组织，以特异性地抑制组织中的氧化作用。此外，该方法还可用于抑制脱水组织中的氧化作用。包埋剂抑制了组织中由氧化暴露或生成的结合位点的形成，否则这些位点在植入时会吸引钙、磷、免疫原因因子或其他钙化前体。在一种方法中，组装的生物假体心脏瓣膜中的组织叶片在脱水和灭菌之前先用醛类包埋剂进行预处理。
• COMPOSITION FOR CURABLE RESIN, CURED PRODUCT OF SAID COMPOSITION, PRODUCTION METHOD FOR SAID COMPOSITION AND SAID CURED PRODUCT, AND SEMICONDUCTOR DEVICE
  申请人：JXTG NIPPON OIL & ENERGY CORPORATION

  公开号：US20200325270A1

  公开（公告）日：2020-10-15

  The invention relates to a curable resin composition containing (A) a multifunctional benzoxazine compound having two or more benzoxazine rings, (B) an epoxy compound having at least one norbornane structure and at least two epoxy groups, (C) a biphenyl type epoxy compound, and (D) a curing agent, and optionally (E) an inorganic filler and (F) a curing accelerator; a cured product thereof; methods of producing the curable resin composition and the cured product; and a semiconductor device in which a semiconductor element is disposed in a cured product obtained by curing a curable resin composition containing components (A) to (D), and optionally components (E) and (F).

  本发明涉及一种可固化树脂组合物，包含(A)一种具有两个或更多苯并噁嗪环的多功能苯并噁嗪化合物，(B)至少具有一个诺伯尔烷结构和至少两个环氧基团的环氧化合物，(C)一种联苯型环氧化合物和(D)一种固化剂，可选地包括(E)一种无机填料和(F)一种固化促进剂；其固化产物；制备该可固化树脂组合物和固化产物的方法；以及半导体器件，其中半导体元件位于通过固化含有组分(A)至(D)和可选组分(E)和(F)的可固化树脂组合物获得的固化产物中。
• Hydrogels and water soluble polymeric carriers for durg delivery
  申请人：The Regents Of The University Of Michigan

  公开号：US20040028745A1

  公开（公告）日：2004-02-12

  Carriers for drug delivery, methods of making such carriers and for associating them to drugs, the resulting carrier and drug combination and methods for drug delivery, particularly controlled or sustained release delivery, using such carrier and drug combinations.

  药物输送载体，制造这种载体的方法以及将它们与药物结合的方法，得到的药物和载体组合以及使用这种药物和载体组合进行药物输送的方法，特别是使用这种药物和载体组合进行控制或持续释放输送。
• Near-infrared-absorbing organic electrochromic materials
  申请人：Wang Zhi Yuan

  公开号：US20080188678A1

  公开（公告）日：2008-08-07

  The invention provides generally a new type of organic electrochromic Near Infrared (NIR)-active materials capable of absorbing and attenuating the light in the NIR region around 1550 nm and forming thin films on electrodes for variable optical attenuator (VOA) applications. They have utility in planar VOA devices. The materials are ruthenium complexes. Unsymmetrical complexes having two different substituents are disclosed, where one substituent is more electron-donating than the other. Complexes which are dimers or trimers (symmetrical or unsymmetrical) are disclosed, as are polymeric complexes. Crosslinked polymeric complex films are also disclosed.

  该发明通常提供了一种新型的有机电致变色近红外（NIR）活性材料，能够吸收和衰减大约1550纳米附近的NIR区域的光，并形成薄膜在电极上，用于可变光学衰减器（VOA）应用。它们在平面VOA设备中具有实用性。这些材料是钌配合物。披有两种不同取代基的非对称配合物被披露，其中一个取代基比另一个更具电子给予性。披有二聚体或三聚体（对称或非对称）的配合物被披露，以及聚合物配合物。还披露了交联聚合物复合薄膜。
• Polymers containing poly(hydroxyalkanoates) and agents for use with medical articles and methods of fabricating the same
  申请人：Hossainy F.A. Syed

  公开号：US20060147412A1

  公开（公告）日：2006-07-06

  Polymers containing poly(hydroxyalkanoates) and agents for use with medical articles and methods of fabricating the same are disclosed. The medical article generally comprises an implantable substrate having a coating, and the coating contains a poly(hydroxyalkanoate).

  本发明公开了含有聚羟基烷酸酯的高分子以及用于医疗器械的制剂和制备方法。医疗器械通常包括具有涂层的可植入基质，而涂层含有聚羟基烷酸酯。